Literature DB >> 7189174

[Treatment of the premenstrual syndrome with a retroprogesterone (Duphaston)].

J R Strecker.   

Abstract

The symptomatology of the premenstrual syndrome is frequently seen in general and gynecological practice. The aim of this study was to examine the therapeutical effect of dydrogesterone (Duphaston) on the typical premenstrual complaints as depression, headache, edema, mastodynia, dysmenorrhea and bleeding irregularities. Oral administration of 20 mg dydrogesterone b.i.d. during the second half of the menstrual cycle could well relieve the complaints mentioned above. Best results of treatment were obtained in cases of dysmenorrhea, bleeding irregularities, depression and edema. In our patients mastodynia was not influenced by dydrogesterone-therapy. As shown by basal body temperature and progesterone in plasma the menstrual cycles remained ovulatory under therapy. The treatment with dydrogesterone was tolerated well in general, blood pressure and body weight were not altered significantly. The majority of patients wished to continue the treatment beyond the period of this study.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7189174

Source DB:  PubMed          Journal:  Fortschr Med        ISSN: 0015-8178


  3 in total

1.  Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review.

Authors:  K Wyatt; P Dimmock; P Jones; M Obhrai; S O'Brien
Journal:  BMJ       Date:  2001-10-06

2.  Progesterone, fluid, and electrolytes in premenstrual syndrome.

Authors:  A J Martin; L J Downey
Journal:  Br Med J       Date:  1980-08-23

Review 3.  The premenstrual syndrome: a review of the present status of therapy.

Authors:  P M O'Brien
Journal:  Drugs       Date:  1982-08       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.